Ascensia Contour Next Link (Bayer)
While the technology used in the Ascensia Contour Next Link (Bayer), to measure blood glucose, has been assessed, the results of the study have not been published and cannot be verified.
|Medaval||None||While a clinical validation is claimed, it cannot be checked properly.|
|Institute of Health Economics (CA)||General use||No evidence provided|
Greene C, Brown D, Wallace JF, Pardo S, Pflug B. Comparative Accuracy of 3 Blood Glucose Monitoring Systems that Communicate with an Insulin Pump. Endocr Pract. 2014 Oct;20(10):1016-21. doi: 10.4158/EP13484.OR. PMID: 24793918.
Measurements from the Ascensia (Bayer) Contour Next Link are compared to those from the J&J OneTouch UltraLink and the Nova Max Link, though not in a formal validation.
Massa GG, Gys I, Op't Eyndt A, Bevilacqua E, Wijnands A, Declercq P, Zeevaert R. Evaluation of the FreeStyle® Libre Flash Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. 2018;89(3):189-99. Epub: 2018 Mar 27. doi: 10.1159/000487361. PMID: 29587254.
Comparison in children and adolescents with T1DM (aged 4 to 18 years) (along with the Roche Accu-Chek Mobile and the JnJ LifeScan OneTouch Verio IQ) to the Abbott FreeStyle Libre Flash (n=26). Authors conclude reasonable agreement but with large interindividual variability and that further studies in children are imperative.